Deutsche Bank analyst upgrades several airline stocks and reiterates ratings reflecting expected benefits from domestic networks and weakened supply backdrop.
Impact of Philips' decision to halt CPAP device sales in the U.S. and its potential market implications. William Blair sees a significant opportunity for Inogen to reclaim market share.
BofA Securities upgrades Air Products & Chemicals to Buy with a price target of $264. Analyst cites valuation disconnect, lower risk in projects, and strong base business.
SentinelOne (NYSE: S) upgraded to Buy, price target raised to $35. Positive outlook on profitability, ARR growth, and market conditions. Strong competition and risks, but potential for top-line and nnARR upside. Trading at a discount compared to peers. Fourth-quarter revenue and EPS projected at $169.26 million and $(0.04).